Revenue: The sum of all revenue fields included for a company's operating activities.
Supernus Pharmaceuticals, Inc. (SUPN) had Revenue of $149.82M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$149.82M |
$-11.83M |
|
$15.76M |
|
$134.06M |
|
$160.08M |
|
$-10.26M |
|
$4.42M |
|
$-5.83M |
|
$-5.83M |
|
$-11.83M |
|
$-11.83M |
|
$-11.83M |
|
$-11.83M |
|
$-10.26M |
|
$9.05M |
|
55.87M |
|
55.87M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$687.58M |
|
$11.34M |
|
$659.71M |
|
$1.35B |
|
$281.77M |
|
-- |
|
$34.81M |
|
$316.58M |
|
$1.03B |
|
$411.56M |
|
$1.03B |
|
55.99M |
|
| Cash Flow Statement Financials | |
$30.60M |
|
$37.32M |
|
$-21.40M |
|
$69.33M |
|
$115.85M |
|
$46.52M |
|
$8.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.48% |
|
-6.85% |
|
-6.85% |
|
-- |
|
-3.89% |
|
-7.89% |
|
$30.27M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.32 |
|
1.03 |
|
87.49 |
|
-1.15% |
|
-2.87% |
|
-0.88% |
|
-1.15% |
|
$18.41 |
|
$0.54 |
|
$0.55 |
|